Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited‐stage small‐cell lung cancer?

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|5|605-612

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.5, 2015-09, pp. : 605-612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small‐cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 643-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection of proper candidates with resected pathological stage IIIA‐N2 non‐small cell lung cancer for postoperative radiotherapy

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evolution of induction chemotherapy for non‐small cell lung cancer over the last 30 years: A surgical appraisal

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 731-740

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of chemotherapy for newly diagnosed advanced non‐small cell lung cancer with venous thromboembolism

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 772-777

John Wiley & Sons Inc

Access to resources Recommend Favorite